Methods for Introducing Mutations That Alter the Probability of Intranucleic Acid Base Pairing of a Conserved Structured Nucleotide and Related Compositions
AssigneeCureLab, Inc.
InventorsAndrey Chursov, Alexander Shneider
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to methods for introducing mutations that alter the probability of intranucleic acid base pairing of a conserved structured nucleotide in a nucleic acid. The present invention also provide methods for making mutant pathogenic organisms suitable as live attenuated vaccines, animal and human diagnostics, and for identifying suitable drug targets.
Claims28
A method of introducing a mutation into a nucleic acid that alters the probability of intranucleic acid base pairing of a conserved structured nucleotide comprising:
- a) introduction of a mutation at an identity conserved nucleotide position i, 0<i<L;+1, wherein L;
- is the length of the nucleic acid sequence, in the nucleotide sequence corresponding to said nucleic acid;
- b) determination of the probability of intranucleic acid base pairing for a structure conserved nucleotide position j, 0<j<Lj+1, in said nucleic acid sequence in the presence of the mutation (Pm);
- c) comparison of Pm to a threshold probability of intranucleic acid base pairing for a structure conserved nucleotide position j in said nucleic acid sequence comprising;
- i) Comparison of Pm to Pmin wherein Pmin is a minimum threshold probability of intranucleic acid base pairing for a structure conserved nucleotide position j in said nucleic acid sequence;
- or,
- ii) Comparison of Pm to Pmax wherein PmaX is a maximum threshold probability of intranucleic acid base pairing for a structure conserved nucleotide position j in said nucleic acid sequence;
- wherein if Pm<Pmm or Pm>Pmax said mutation is identified as a structure conserved altering mutation;
- and,
- d) introduction of said mutation into said nucleic acid when said mutation is a structure conserved altering mutation.
The method of claim 18, wherein said pathogenic organism is selected from the group consisting of:
- Torque Teno virus (Transfusion transmitted virus), Ippy virus, Lassa fever virus, Lujo virus, Lymphocytic (strains), Lymphocytic choriomeningitis virus (other strains), Mobala virus, Mopeia virus, Amapari virus, Flexal virus, Guanarito virus, Junin virus, Latino virus, Machupo virus, Parana virus, Pichinde virus, Sabia virus, Tamiami virus, Whitewater Arroyo virus, Borna disease virus, Akabane virus, Bhanja virus, Bunyamwera virus, California encephalitis virus, Germiston virus, Oropouche virus, Belgrade (Dobrava) virus, Hantaan virus (Korean haemorrhagic fever), Puumala virus, Prospect Hill virus, Seoul virus, Sin Nombre virus (formerly Muerto Canyon), Crimean/Congo haemorrhagic fever virus, Hazara virus, Rift valley fever virus, Sandfly fever virus, Toscana virus, Norovirus (formerly Norwalk virus), Sapo virus, 29E virus, OC43 virus, SARS virus, Ebola Cote d'Ivoire virus, Ebola Reston virus, Ebola Sudan virus, Ebola Zaire virus, Marburg virus, Absettarov virus, Central European tick-borne encephalitis virus, Dengue viruses types 1-4, GB virus C (Hepatitis G virus), Hanzalova virus, Hepatitis C virus, Hypr virus, Israel turkey meningitis virus, Japanese encephalitis virus, Kumlinge virus, Kyasanur forest disease virus, Louping ill virus, Murray Valley encephalitis virus, Negishi virus, Omsk haemorrhagic fever virus, Powassan virus, Rocio virus, Russian spring summer encephalitis virus, Sal Vieja virus, San Perlita virus, Spondweni virus, St Louis encephalitis virus, Tick-borne encephalitis virus, Wesselsbron virus, West Nile fever virus, Yellow fever virus, Hepatitis B virus, Hepatitis D virus (delta), Cytomegalovirus, Epstein-Barr virus, Herpesvirus simiae (B virus), Herpes simplex virus types 1 and 2, Human herpesvirus type 6—HHV6, Human herpesvirus type 7—HHV7, Human herpesvirus type 8—HHV8 (Kaposi's sarcoma-associated herpesvirus), Varicella-zoster virus, Dhori virus, Influenza virus types A, B and C, Thogoto virus, BK virus, JC virus, KI virus, Simian virus 40 (SV40), WU virus, Human papillomaviruses, Hendra virus (formerly equine morbillivirus), Human metapneumo virus, Measles virus, Mumps virus, Newcastle disease virus, Nipah virus, Parainfluenza virus (Types 1 to 4), Respiratory syncytial virus (human), Bocavirus genus, Parvovirus B19, Human partetravirus (Parv4/Parv5), Acute haemorrhagic conjunctivitis virus (AHC), Coxsackieviruses, Echoviruses, Hepatitis A virus (human enterovirus type 72), Polioviruses, Rhinoviruses, Molluscum contagiosum virus, Buffalopox virus, Cowpox virus, Elephantpox virus, Monkeypox virus, Rabbitpox virus, Vaccinia virus, Variola virus (major and minor), Whitepox virus, Orf virus, Pseudocowpox virus (Milker's nodes virus), Tana virus, Yaba virus, Coltivirus, Human rotaviruses, Orbiviruses, Reoviruses, Human immunodeficiency viruses, Human T-cell lymphotropic viruses (HTLV) types 1 and 2, Simian immunodeficiency virus, Xenotropic murine leukemia virus-related virus, Australian bat lyssavirus, Duvenhage virus, European bat lyssaviruses 1 and 2, Lagos bat virus, Mokola virus, Piry virus, Rabies virus, Vesicular stomatitis virus, Bebaru virus, Chikungunya virus, Eastern equine encephalitis virus, Everglades virus, Getah virus, Mayaro virus, Middleburg virus, Mucambo virus, Ndumu virus, O'nyong-nyong virus, Ross river virus, Sagiyama virus, Semliki forest virus, Sindbis virus, Tonate virus, Venezuelan equine encephalitis virus, Western equine encephalitis virus, Rubella virus, Berne virus, Breda virus, Porcine torovirus, Hepatitis E virus, Actinobacillus actinomycetemcomitans, Actinomadura madurae, Actinomadura pelletieri, Actinomyces gerencseriae, Actinomyces israelii, Actinomyces spp, Alcaligenes spp, Bacillus anthracis, Bacillus cereus, Bacteroides fragilis, Bacteroides spp, Bartonella bacilliformis, Bartonella quintana, Bartonella spp, Bordetella bronchiseptica, Bordetella parapertussis, Bordetella pertussis, Bordetella spp, Borrelia burgdorferi, Borrelia duttonii, Borrelia recurrentis, Borrelia spp, Brachyspira spp (formerly Serpulina spp), Brucella abortus, Brucella canis, Brucella melitensis, Brucella suis, Burkholderia cepacia, Burkholderia mallei (formerly Pseudomonas mallei), Burkholderia pseudomallei (formerly Pseudomonas pseudomallei), Campylobacter fetus, Campylobacter jejuni, Campylobacter spp, Cardiobacterium hominis, Chlamydia trachomatis, Chlamydophila pneumoniae, Chlamydophila psittaci, Clostridium botulinum, Clostridium perfringens, Clostridium tetani, Clostridium spp, Corynebacterium diphtheriae, Corynebacterium haemolyticum, Corynebacterium pseudotuberculosis, Corynebacterium pyogenes, Corynebacterium ulcerans, Corynebacterium spp, Coxiella burnetii, Edwardsiella tarda, Ehrlichia sennetsu (Rickettsia sennetsu), Ehrlichia spp, Eikenella corrodens, Enterobacter aerogenes/cloacae, Elizabethkingia meningoseptica (formerly Flavobacterium meningosepticum), Enterobacter spp, Enterococcus spp, Erysipelothrix rhusiopathiae, Escherichia coli, verocytotoxigenic strains (eg 0157:H7 or O103), Francisella tularensis (Type A), Francisella tularensis (Type B), Fusobacterium necrophorum, Fusobacterium spp, Gardnerella vaginalis, Haemophilus ducreyi, Haemophilus influenzae, Haemophilus spp, Helicobacter pylori, Klebsiella oxytoca, Klebsiella pneumoniae, Klebsiella spp, Legionella pneumophila, Legionella spp, Leptospira interrogans (all serovars), Listeria ivanovii, Listeria monocytogenes, Moraxella catarrhalis, Morganella morganii, Mycobacterium africanum, Mycobacterium avium/intracellulare, Mycobacterium bovis, Mycobacterium chelonae, Mycobacterium fortuitum, Mycobacterium kansasii, Mycobacterium leprae, Mycobacterium malmoense, Mycobacterium marinum, Mycobacterium microti, Mycobacterium paratuberculosis, Mycobacterium scrofulaceum, Mycobacterium simiae, Mycobacterium szulgai, Mycobacterium tuberculosis, Mycobacterium ulcerans, Mycobacterium xenopi, Mycoplasma caviae, Mycoplasma hominis, Mycoplasma pneumoniae, Neisseria gonorrhoeae, Neisseria meningitidis, Nocardia asteroides, Nocardia brasiliensis, Nocardia farcinica, Nocardia nova, Nocardia otitidiscaviarum, Pasteurella multocida, Pasteurella spp, Peptostreptococcus anaerobius, Peptostreptococcus spp, Plesiomonas shigelloides, Porphyromonas spp, Prevotella spp, Proteus mirabilis, Proteus penneri, Proteus vulgaris, Providencia alcalifaciens, Providencia rettgeri, Providencia spp, Pseudallescheria boydii, Pseudomonas aeruginosa, Rhodococcus equi, Rickettsia akari, Rickettsia Canada, Rickettsia conorii, Rickettsia montana, Rickettsia prowazekii, Rickettsia rickettsii, Rickettsia tsutsugamushi, Rickettsia typhi (Rickettsia mooseri), Rickettsia spp, Salmonella arizonae, Salmonella enterica serovar enteritidis, Salmonella enterica serovar typhimurium 2, Salmonella paratyphi A, Salmonella paratyphi B/java, Salmonella paratyphi CI choleraesuis, Salmonella typhi, Salmonella spp, Shigella boydii, Shigella dysenteriae, Shigella flexneri, Shigella sonnei, Staphylococcus aureus, Streptobacillus moniliformis, Streptococcus agalactiae, Streptococcus dysgalactiae equisimilis, Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus suis, Streptococcus spp, Treponema carateum, Treponema pallidum, Treponema pertenue, Treponema spp, Ureaplasma parvum, Ureaplasma urealyticum, Vibrio cholerae (including El Tor), Vibrio parahaemolyticus, Vibrio spp, Yersinia enterocolitica, Yersinia pestis, Yersinia pseudotuberculosis, and Yersinia spp
A method of identifying human and/or animal mutations which may cause a disease comprising:
- a) Identification of structured RNA regions for a functionally important gene involved into disease prevention and/or pathogenesis. b) Testing a mutation for its ability to disrupt one or more structured RNA regions of the nucleic acid sequence of said gene.
Dependencies are inferred from the claim text.